Active Ingredient (Generic Name) | Capecitabine (500mg) |
---|---|
Indication | Capnat 500mg Tablet is used in the treatment of cancer of breast, colon, and rectum. |
Manufacturer | Natco Pharma Ltd |
Packaging | 1x10 |
Strength | 500 mg |
Delivery Time | 8 Days |
Capnat 500 mg Tablet (Capecitabine)
Capnat 500 mg Tablet is an oral chemotherapy medication containing Capecitabine, a fluoropyrimidine carbamate antimetabolite that is converted in the body to 5-fluorouracil (5-FU), a substance that interferes with DNA synthesis in cancer cells. Capnat is used in the treatment of various cancers including:
Breast cancer
Colorectal cancer (colon and rectum)
Metastatic cancers involving the above types
Capnat is most often used in patients whose cancer has spread to other parts of the body or in combination with other chemotherapy drugs.
Capecitabine is a prodrug that is enzymatically converted to 5-FU at the tumor site. 5-FU inhibits thymidylate synthase, thereby interfering with DNA replication and tumor cell proliferation.
Targeted oral chemotherapy option
Reduces need for hospital-administered IV chemotherapy
High patient compliance due to convenient tablet form
Widely used in oncology centers globally
Supplied in bulk packs (10 x 10 tablets) for clinical use
Capnat 500 mg Tablet (Capecitabine)
Capnat 500 mg Tablet is an oral chemotherapy medication containing Capecitabine, a fluoropyrimidine carbamate antimetabolite that is converted in the body to 5-fluorouracil (5-FU), a substance that interferes with DNA synthesis in cancer cells. Capnat is used in the treatment of various cancers including:
Breast cancer
Colorectal cancer (colon and rectum)
Metastatic cancers involving the above types
Capnat is most often used in patients whose cancer has spread to other parts of the body or in combination with other chemotherapy drugs.
Capecitabine is a prodrug that is enzymatically converted to 5-FU at the tumor site. 5-FU inhibits thymidylate synthase, thereby interfering with DNA replication and tumor cell proliferation.
Targeted oral chemotherapy option
Reduces need for hospital-administered IV chemotherapy
High patient compliance due to convenient tablet form
Widely used in oncology centers globally
Supplied in bulk packs (10 x 10 tablets) for clinical use